• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Neuland Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3800.0
  • ISIN : INE794A01010
23,320.00 113 (0.49%)
  • As on 15 Aug 2026 (EOD)

  • Today’s Low

    23,030.00

  • Today’s High

    23,650.00

  • Open

    23,100.00

  • Perv Close

    23,207.00

  • 52W Low

    11,500.00

  • 52W High

    23,650.00

Key Indicators

  • P/E(TTM)

    60.21

  • Mar.Cap (₹Cr.)

    29,919.30

  • Div & Yield %

    0.15

  • Book Value(₹)

    1,453.59

  • Debt-Equity Ratio

    0.49

  • AGM Date

    14-Aug-2026

  • EPS

    387.19

  • P/E Ratio

    60.21

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    29,919.30

  • RONW (%)

    26.38

  • ROCE (%)

    33.01

Score Board

  • Equity (₹ in Cr.)

    12.83

  • BV (₹)

    1,453.60

  • Sales( ₹ in Cr.)

    2,022.99

  • NP (in Cr.)

    360.22

  • NP Var(%)

    108.0

  • Div%

    340.0

  • CPS (₹)

    352.30

  • EPS (₹)

    280.80

  • Traded Value (₹ in Lakhs)

    29,908.40

  • 52 Week High

    23,650.00

  • 52 Week Low

    11,500.00

  • Price BSE

    23312.0

  • Price NSE

    23,320.00

  • Market Capital( in Cr.)

    29,908.40

  • P/C Ratio

    66.20

  • P/E Ratio

    83.00

  • Price Vs.BV

    280.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,022.99 1,476.84 1,558.58 1,191.20 951.08 936.91
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,022.99 1,476.84 1,558.58 1,191.20 951.08 936.91
Other Income 30.16 96.91 12.54 9.75 2.08 16.09
Stock Adjustments 64.26 -12.83 55.14 9.51 15.41 1.24
Total Income 2,117.41 1,560.92 1,626.26 1,210.46 968.57 954.24
EXPENDITURE :            
Raw Materials 823.89 578.45 636.49 491.98 441.79 443.04
Power and Fuel Cost 58.14 50.56 48.72 48.62 42.21 39.21
Employee Cost 328.82 261.40 248.53 194.84 175.76 144.02
Other Manufacturing Expenses 129.35 108.66 103.73 82.69 84.92 73.71
Selling and Administration Expenses 154.17 120.52 104.29 88.50 70.50 79.80
Miscellaneous Expenses 19.63 22.11 10.04 22.77 9.12 11.93
Employee Benefit Expenses 328.82 261.40 248.53 194.84 175.76 144.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,514.00 1,141.71 1,151.81 929.40 824.29 791.71
Operating Profit 603.41 419.22 474.47 281.06 144.27 162.54
Interest 23.95 8.30 14.00 13.07 13.49 17.90
Gross Profit 579.46 410.92 460.47 267.99 130.78 144.64
Depreciation 91.73 65.54 59.70 52.78 49.04 39.68
Profit Before Tax 487.73 345.38 400.77 215.21 81.74 104.96
Current Tax 128.88 73.65 99.59 50.39 20.42 12.48
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -4.26 12.29 1.59 1.70 -2.22 12.18
Reported Net Profit 363.11 259.43 299.60 163.12 63.53 80.29
Extraordinary Items 2.88 86.29 -0.30 -0.66 -1.36 9.81
Adjusted Net Profit 360.23 173.14 299.90 163.78 64.89 70.48
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 988.77 747.31 460.54 303.84 244.15 166.42
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 15.40 17.96 12.83 6.41 3.85 2.57
P & L Balance carried down 1,336.48 988.77 747.31 460.54 303.84 244.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 340.00 120.00 140.00 100.00 50.00 50.00
Dividend Per Share(Rs) 34.00 12.00 14.00 10.00 5.00 5.00
Earnings Per Share-Unit Curr 281.47 201.10 232.24 126.44 49.25 62.24
Earnings Per Share(Adj)-Unit Curr 281.47 201.10 232.24 126.44 49.25 62.24
Book Value 1,445.69 1,175.89 988.88 765.49 647.06 605.44
Book Value(Adj)-Unit Curr 1,445.69 1,175.89 988.88 765.49 647.06 605.44

Shareholding Pattern

  • Promoter Group

    32.62%

  • Public Share Holding

    67.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 200 200.00 200 200
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 200 0.00 200 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 851,282 6.64 851,282 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 3,333,352 25.98 3,333,352 1
Others 0 0.00 0 0
Sub Total 4,184,634 32.62 4,184,634 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 55 0.00 55 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,704,844 21.08 2,704,844 173
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 163,689 1.28 163,689 9
Mutual Funds / UTI 1,624,317 12.66 1,624,317 32
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 330,687 2.58 330,687 38
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,823,592 37.60 4,823,592 253
2] Non Institution
Bodies Corporate 599,495 4.67 598,695 799
Clearing Members 779 0.01 779 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 149,901 1.17 137,401 1,424
Foreign Non Institution Other 100 0.00 0 1
Hindu Undivided Families 74,966 0.58 73,566 1,035
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 876,207 6.83 876,207 9
Individuals holding nominal share capital up to Rs. 1 lakh 2,058,637 16.05 2,018,329 40,784
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,720 0.15 18,720 15
Others 42,658 0.33 42,658 1
Sub Total 3,821,463 29.79 3,766,355 44,072
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,829,889 100.00 12,774,781 44,340

Company Background

Neuland Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Neuland Laboratories Ltd
  • BSE Code : 3800.0
  • ISIN : INE794A01010

  • Incorporation Year

    1984

  • Registered Office

    11 Th Floor Phoenix IVY Buildi
    Plot No 573A-III Road No 82, Hyderabad,
    Telangana-500035

  • Telephone

    91-40-30211600

  • FAX

    91-40-30211602

  • Chairman

    D R Rao

  • Managing Director

  • Company Secretary

    Sarada Bhamidipati

  • Auditor

    MSKA & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Neuland Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Neuland Labs. 23,311.50 2,053.15 2,022.99 60.21 26.50
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77